» Authors » Robert M Verdijk

Robert M Verdijk

Explore the profile of Robert M Verdijk including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 143
Citations 1714
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nell R, Versluis M, Cats D, Mei H, Verdijk R, Kroes W, et al.
Sci Rep . 2025 Mar; 15(1):8167. PMID: 40059100
Uveal melanoma is a lethal intraocular tumour, in which the presence of various genetic alterations correlates with the risk of metastatic dissemination and survival. Here, we tested the detectability of...
2.
Hinz F, Friedel D, Korshunov A, Ippen F, Bogumil H, Banan R, et al.
Acta Neuropathol . 2025 Feb; 149(1):12. PMID: 39899075
IDH-mutant astrocytomas are diffuse gliomas that are defined by characteristic mutations in IDH1 or IDH2 and do not have complete 1p/19q co-deletion. The established grading criteria include histological features of...
3.
Khatab S, Colijn J, Naus N, Verdijk R, Hotte G
Ocul Oncol Pathol . 2024 Dec; 10(4):227-233. PMID: 39660252
Introduction: Undifferentiated pleomorphic sarcoma (UPS), formerly known as malignant fibrous histiocytoma, is a high-grade soft tissue sarcoma arising from mesenchymal stem cells. UPSs are rare and account for about 5%...
4.
Stalhammar G, Vishnevskia-Dai V, Verdijk R, Moulin A
Ocul Oncol Pathol . 2024 Dec; 10(4):197-205. PMID: 39660247
Introduction: Clear evidence for the best clinical management of uveal melanoma is lacking in some areas. Therefore, reports on expert opinions in the field can be valuable. Methods: A questionnaire...
5.
Nguyen J, Drabarek W, Leeflang A, Brands T, van den Bosch T, Verdijk R, et al.
Invest Ophthalmol Vis Sci . 2024 Oct; 65(12):11. PMID: 39374010
Purpose: Unfortunately, treatment of patients with uveal melanoma (UM) with metastatic disease is limited. Twenty percent of patients with UM harbor a mutation in the splicing factor gene SF3B1, suggesting...
6.
Kemps P, Woei-A-Jin F, Quint K, van den Bos C, Naeije L, van Laar J, et al.
Blood Adv . 2024 Oct; 9(3):439-444. PMID: 39361730
No abstract available.
7.
Kemps P, Baelde H, Vorderman R, Stelloo E, Swennenhuis J, Szuhai K, et al.
Blood . 2024 Sep; 144(23):2439-2455. PMID: 39316650
Juvenile xanthogranuloma (JXG) is a histiocytic neoplasm that usually presents in the skin. Rarely, extracutaneous localizations occur; the genetic drivers of this clinical variant of JXG remain incompletely characterized. We...
8.
van Meyel S, Verdijk R, Therssen N, Paridaens D
Ophthalmic Plast Reconstr Surg . 2024 Jul; 40(6):e230-e232. PMID: 39077973
Nerve sheath myxomas are extremely rare myxoid peripheral nerve sheath tumors with a predilection for the distal extremities, particularly common in the fingers and knees. Here, the authors report a...
9.
Pellerino A, Verdijk R, Nichelli L, Andratschke N, Idbaih A, Goldbrunner R
Cancers (Basel) . 2024 Jul; 16(14). PMID: 39061148
Background: Primary meningeal melanocytic tumors are ultra-rare entities with distinct histological and molecular features compared with other melanocytic or pigmented lesions, such as brain and leptomeningeal metastases from metastatic melanoma....
10.
Gelmi M, de Ru A, Van Veelen P, Tjokrodirijo R, Stern M, Houy A, et al.
Invest Ophthalmol Vis Sci . 2024 Jul; 65(8):37. PMID: 39042403
Purpose: Cell lines are being used in preclinical uveal melanoma (UM) research. Because not all cell lines harbor typical GNAQ or GNA11 hotspot mutations, we aimed at better classifying them...